Lv1
50 积分 2021-09-03 加入
China’s innovation in translational medicine: rethinking early-stage clinical development
10小时前
待确认
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
7天前
已完结
Influence of antibody–drug conjugate cleavability, drug-to-antibody ratio, and free payload concentration on systemic toxicities: A systematic review and meta-analysis
12天前
已完结
Beyond Convenience: Does Subcutaneous Pembrolizumab Add Value for Patients and Health Systems?
14天前
已完结
Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization
21天前
已完结
Hallmarks of cancer—Then and now, and beyond
1个月前
已完结
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
2个月前
已完结
Circulating tumor DNA as a biomarker in early phase clinical trials
2个月前
已完结
Eleven clinical trials that will shape medicine in 2026
3个月前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
3个月前
已完结
皖公网安备34019202002308
